Circulation journal : official journal of the Japanese Circulation Society · 2026
Symptomatic Pulmonary Regurgitation Without Right Ventricular Enlargement Accompanied by Biventricular Diastolic Dysfunction in Repaired Tetralogy of Fallot and Related Diseases.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yamabe Sayuri, Kayama Kiyomi, Tsuruta Yoshiro, Kawada Yu, Mizoguchi Tatsuya, Yokoi Masashi, Mori Kento, Ito Tsuyoshi, Matsui Kyoko, Kitada Shuichi, Goto Toshihiko, Yasuda Masahiro, Kimura Hitomi, Koyama Satoshi, Shinohara Tsutomu, Itatani Keiichi, Seo Yoshihiro
Аннотация
BACKGROUND: In repaired tetralogy of Fallot (TOF) and related diseases, reoperation for pulmonary regurgitation (PR) may be delayed unless marked right ventricular (RV) enlargement is present.
METHODS AND RESULTS: 32 patients with significant PR post-repair underwent catheterization and 4D flow MRI for reoperation evaluation. The Non-severe RV Dilation group (n=20) did not meet the surgical volume criteria, whereas the Severe RV Dilation group (n=12) did. The Non-severe RV Dilation group had higher biventricular filling pressures. The RV-Energy loss index in both groups was high.
CONCLUSIONS: Diastolic dysfunction could serve as a therapeutic target in PR patients with heterogeneous etiologies.
METHODS AND RESULTS: 32 patients with significant PR post-repair underwent catheterization and 4D flow MRI for reoperation evaluation. The Non-severe RV Dilation group (n=20) did not meet the surgical volume criteria, whereas the Severe RV Dilation group (n=12) did. The Non-severe RV Dilation group had higher biventricular filling pressures. The RV-Energy loss index in both groups was high.
CONCLUSIONS: Diastolic dysfunction could serve as a therapeutic target in PR patients with heterogeneous etiologies.